Info

VINNAPAS® EP 3360

A dispersion for environmentally sound wall paints free of unpleasant odors – ideal for hotels, hospitals, schools and children’s bedrooms.

Close

Segment Information by Division

January 1 to December 31

 (XLS:) Download XLS

 

  

 

€ million

  

Silicones

  

Polymers

  

Bio­solutions

  

Poly­silicon

  

Other

  

Discontinued operations

  

Consoli­dation

  

Group2

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

1

Intangible assets; property, plant and equipment; investment property

2

Adjusted in accordance with IFRS 5 (Non-Current Assets Held for Sale and Discontinued Operations)

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 20.

2017

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

External sales

  

2,200.0

  

1,225.6

  

205.8

  

1,101.3

  

150.8

  

–

  

–

  

4,883.5

Internal sales

  

0.2

  

19.5

  

0.1

  

22.7

  

18.0

  

–

  

-19.8

  

40.7

Total sales

  

2,200.2

  

1,245.1

  

205.9

  

1,124.0

  

168.8

  

–

  

-19.8

  

4,924.2

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT

  

362.2

  

168.1

  

26.1

  

-87.6

  

-48.2

  

–

  

3.1

  

423.7

Depreciation and impairment losses/reversals

  

82.7

  

37.5

  

11.4

  

378.0

  

80.8

  

–

  

–

  

590.4

EBITDA

  

444.9

  

205.6

  

37.5

  

290.4

  

32.6

  

–

  

3.1

  

1,014.1

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT includes:

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Result from investments in joint ventures and associates

  

2.0

  

–

  

–

  

–

  

40.0

  

–

  

–

  

42.0

Impairment of fixed assets

  

–

  

–

  

–

  

–

  

–

  

–

  

–

  

–

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Asset additions1

  

142.8

  

48.1

  

15.7

  

57.6

  

62.5

  

19.5

  

–

  

346.2

Additions to financial assets

  

–

  

–

  

–

  

–

  

0.1

  

–

  

–

  

0.1

Asset additions

  

142.8

  

48.1

  

15.7

  

57.6

  

62.6

  

19.5

  

–

  

346.3

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Assets (Dec. 31)

  

1,471.1

  

609.3

  

157.7

  

2,395.3

  

2,202.4

  

–

  

-0.1

  

6,835.7

Liabilities (Dec. 31)

  

688.8

  

270.9

  

66.0

  

759.6

  

1,881.2

  

–

  

-0.1

  

3,666.4

Net assets (Dec. 31)

  

782.3

  

338.4

  

91.7

  

1,635.7

  

321.2

  

–

  

–

  

3,169.3

Investments in joint ventures and associates included in net assets (Dec. 31)

  

9.9

  

–

  

–

  

–

  

554.7

  

–

  

–

  

564.6

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Research and development expenses

  

58.6

  

29.3

  

6.0

  

22.6

  

36.6

  

–

  

–

  

153.1

Employees (Dec. 31)

  

4,737

  

1,539

  

533

  

2,538

  

4,464

  

–

  

–

  

13,811

Employees (average)

  

4,708

  

1,519

  

528

  

2,527

  

4,441

  

–

  

–

  

13,723

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

2016

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

External sales

  

2,001.0

  

1,176.4

  

206.4

  

1,008.7

  

83.4

  

–

  

–

  

4,475.9

Internal sales

  

0.1

  

18.4

  

–

  

86.8

  

79.2

  

–

  

-26.2

  

158.3

Total sales

  

2,001.1

  

1,194.8

  

206.4

  

1,095.5

  

162.6

  

–

  

-26.2

  

4,634.2

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT

  

280.8

  

223.7

  

25.7

  

-117.1

  

-76.0

  

–

  

0.4

  

337.5

Depreciation and impairment losses/reversals

  

80.4

  

37.3

  

11.3

  

403.0

  

86.2

  

–

  

-0.2

  

618.0

EBITDA

  

361.2

  

261.0

  

37.0

  

285.9

  

10.2

  

–

  

0.2

  

955.5

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT includes:

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Income from investments in joint ventures and associates

  

0.2

  

–

  

–

  

–

  

–

  

–

  

–

  

0.2

Impairment of fixed assets

  

–

  

–

  

–

  

-2.5

  

–

  

–

  

–

  

-2.5

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Asset additions1

  

88.6

  

37.5

  

9.1

  

130.0

  

72.9

  

89.5

  

–

  

427.6

Change in the scope of consolidation

  

26.1

  

–

  

11.2

  

–

  

–

  

–

  

–

  

37.3

Asset additions

  

114.7

  

37.5

  

20.3

  

130.0

  

72.9

  

89.5

  

–

  

464.9

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Assets (Dec. 31)

  

1,379.8

  

580.2

  

151.9

  

3,018.1

  

1,326.9

  

1,034.4

  

-29.7

  

7,461.6

Liabilities (Dec. 31)

  

851.8

  

291.2

  

70.9

  

1,168.1

  

1,879.5

  

631.4

  

-24.5

  

4,868.4

Net assets (Dec. 31)

  

528.0

  

289.0

  

81.0

  

1,850.0

  

-552.6

  

403.0

  

-5.2

  

2,593.2

Investments in joint ventures and associates included in net assets (Dec. 31)

  

11.2

  

–

  

–

  

–

  

–

  

–

  

–

  

11.2

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Research and development expenses

  

53.7

  

30.4

  

6.2

  

18.3

  

41.4

  

–

  

–

  

150.0

Employees (Dec. 31)

  

4,566

  

1,484

  

510

  

2,490

  

4,398

  

3,757

  

–

  

17,205

Employees (average)

  

4,468

  

1,480

  

508

  

2,448

  

4,403

  

3,811

  

–

  

17,118